HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mamoru Tasaki Selected Research

Protein Kinase C-theta

1/2019Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions.
11/2018A novel 2,4-diaminopyrimidine derivative as selective inhibitor of protein kinase C theta prevents allograft rejection in a rat heart transplant model.
7/2015Optimization of 2,4-diamino-5-fluoropyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions and P-gp liability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mamoru Tasaki Research Topics

Disease

3Neoplasms (Cancer)
12/2021 - 01/2020
2Rheumatoid Arthritis
01/2019 - 07/2015
2Autoimmune Diseases (Autoimmune Disease)
11/2018 - 12/2014
2Inflammation (Inflammations)
12/2014 - 06/2013
1Extranodal Extension
01/2020
1Arthritis (Polyarthritis)
12/2014
1Respiratory Hypersensitivity
06/2013
1Asthma (Bronchial Asthma)
06/2013
1Blindness (Hysterical Blindness)
01/2003
1Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
01/2003

Drug/Important Bio-Agent (IBA)

3Interleukin-7 (Interleukin 7)IBA
12/2021 - 01/2020
3Interleukin-12 (IL 12)IBA
12/2021 - 01/2020
3Protein Kinase C-thetaIBA
01/2019 - 07/2015
2Immune Checkpoint InhibitorsIBA
12/2021 - 01/2020
2Pharmaceutical PreparationsIBA
12/2014 - 06/2013
1CTLA-4 AntigenIBA
01/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
12/2014
1AS2521780IBA
12/2014
1AntigensIBA
06/2013
1ASP5642IBA
06/2013
1ramatrobanIBA
06/2013
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
06/2013
1Retinaldehyde (Retinal)IBA
01/2003

Therapy/Procedure

1Immunotherapy
01/2020